This topic contains a solution. Click here to go to the answer

Author Question: A prescriber has ordered a beta1-agonist medication for a patient. A nurse understands that the ... (Read 37 times)

beccaep

  • Hero Member
  • *****
  • Posts: 535
A prescriber has ordered a beta1-agonist medication for a patient. A nurse understands that the patient who would most likely benefit from a beta1 agonist would be a patient with which of the following health alterations?
 
  a. Heart failure
  b. Hypertension
  c. Asthma
  d. Glaucoma

Question 2

When a patient is monitored for aminoglycoside toxicity, what are the key aspects of assessment? You may select more than one answer.
 
  a. Skin integrity
  b. Sense of hearing
  c. Visual acuity
  d. Hair loss
  e. Renal function



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

cdmart10

  • Sr. Member
  • ****
  • Posts: 332
Answer to Question 1

A
Therapeutic applications of beta1 activation include cardiac arrest, heart failure, shock, and AV heart block.
Hypertension is not an indication for the use of a beta1-agonist medication.
Asthma would be most effectively managed with a beta2-agonist medication.
Glaucoma is not an indication for use of a beta1-agonist medication.

Answer to Question 2

b,




beccaep

  • Member
  • Posts: 535
Reply 2 on: Jul 23, 2018
Thanks for the timely response, appreciate it


nyrave

  • Member
  • Posts: 344
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Blood is approximately twice as thick as water because of the cells and other components found in it.

Did you know?

In the United States, an estimated 50 million unnecessary antibiotics are prescribed for viral respiratory infections.

Did you know?

The average human gut is home to perhaps 500 to 1,000 different species of bacteria.

Did you know?

The first-known contraceptive was crocodile dung, used in Egypt in 2000 BC. Condoms were also reportedly used, made of animal bladders or intestines.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

For a complete list of videos, visit our video library